Silo Pharma, Inc. — Director's Dealing 2014

Aug 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Point Capital, Inc. (PTCI)
CIK: 0001514183
Period of Report: 2014-07-30

Reporting Person: Parker Walter Van Eps (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-30	Common Stock	A	37500	—	Acquired	37500	Direct

Footnotes

F1: Issued to the reporting person as compensation for serving as director.